Cited 0 times in
Giredestrant (GDC-9545) vs physician choice of endocrine monotherapy (PCET) in patients (pts) with ER+, HER2-locally advanced/metastatic breast cancer (LA/mBC): Primary analysis of the phase II, randomised, open-label acelERA BC study
DC Field | Value | Language |
---|---|---|
dc.date.accessioned | 2023-06-02T00:55:37Z | - |
dc.date.available | 2023-06-02T00:55:37Z | - |
dc.date.issued | 2022-09 | - |
dc.identifier.issn | 0923-7534 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/194533 | - |
dc.description.statementOfResponsibility | restriction | - |
dc.language | English | - |
dc.publisher | Oxford University Press | - |
dc.relation.isPartOf | ANNALS OF ONCOLOGY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.title | Giredestrant (GDC-9545) vs physician choice of endocrine monotherapy (PCET) in patients (pts) with ER+, HER2-locally advanced/metastatic breast cancer (LA/mBC): Primary analysis of the phase II, randomised, open-label acelERA BC study | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
dc.contributor.googleauthor | M. Martin Jimenez | - |
dc.contributor.googleauthor | E. Lim | - |
dc.contributor.googleauthor | M. Chavez Mac Gregor | - |
dc.contributor.googleauthor | A. Bardia | - |
dc.contributor.googleauthor | J. Wu | - |
dc.contributor.googleauthor | Q. Zhang | - |
dc.contributor.googleauthor | Z. Nowecki | - |
dc.contributor.googleauthor | F. Cruz | - |
dc.contributor.googleauthor | R. Safin | - |
dc.contributor.googleauthor | S-B. Kim | - |
dc.contributor.googleauthor | C. Schem | - |
dc.contributor.googleauthor | A. Montero | - |
dc.contributor.googleauthor | S. Khan | - |
dc.contributor.googleauthor | R. Bandyopadhyay | - |
dc.contributor.googleauthor | M. Shivhare | - |
dc.contributor.googleauthor | M. Patre | - |
dc.contributor.googleauthor | J. Martinalbo | - |
dc.contributor.googleauthor | L. Roncoroni | - |
dc.contributor.googleauthor | P.D. Pérez-Moreno | - |
dc.contributor.googleauthor | J. Sohn | - |
dc.identifier.doi | 10.1016/j.annonc.2022.07.250 | - |
dc.relation.journalcode | J00171 | - |
dc.identifier.eissn | 1569-8041 | - |
dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S0923753422021019 | - |
dc.citation.volume | 33 | - |
dc.citation.number | Supplement 7 | - |
dc.citation.startPage | S633 | - |
dc.citation.endPage | S634 | - |
dc.identifier.bibliographicCitation | ANNALS OF ONCOLOGY, Vol.33(Supplement 7) : S633-S634, 2022-09 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.